2018 Annual Meeting | C141 - Integrating Sleep Medicine Concepts into Your Child Neurology Practice

Date Wednesday 04/25/18

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Suresh Kotagal, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should be able to assess childhood sleep-wake disorders in the office setting and utilize pediatric sleep-specific survey instruments; update their knowledge about the diagnosis and management of primary hypersomnia disorders like narcolepsy and Kleine Levin syndrome; appreciate the bidirectional relationship between epilepsy and sleep; and understand the role that improvements in sleep-wake function may play in rehabilitation after head injury.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
07:00 AM - 09:00 AM	Luncheon	Introduction Suresh Kotagal, MD, FAAN
07:05 AM - 07:30 AM	Speaker	Assessment of Sleep-wake Disorders Suresh Kotagal, MD, FAAN
07:30 AM - 07:55 AM	Speaker	Diagnosis and Management of Primary Hypersomnia Conditions Kiran P. Maski, MD
07:55 AM - 08:20 AM	Speaker	Sleep After Head Injury Anne M. Morse, DO
08:20 AM - 08:45 AM	Speaker	The Bedfellows: Sleep and Epilepsy Sanjeev V. Kothare, MD, FAAN
08:45 AM - 08:55 AM	Q&A	Questions and Answers
08:55 AM - 09:00 AM	Closing Remarks	Closing Remarks Suresh Kotagal, MD, FAAN

Faculty Disclosures
Suresh Kotagal, MD, FAAN	No disclosure on file
Sanjeev V. Kothare, MD, FAAN	Dr. Kothare has nothing to disclose.
Kiran P. Maski, MD	An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Anne M. Morse, DO	Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Hayes solicitors. Dr. Morse has received publishing royalties from a publication relating to health care. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with DAMM Good Sleep, LLC.

��ɫ��

��ɫ��